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Cell death: Drosophila Apaf-1 — no longer in the (d)Ark
Kristin White
The recent discovery and characterization of Ark, the
Drosophila homolog of the mammalian cell-death
adaptor protein Apaf-1, have revealed that, like Apaf-1,
this protein is important in multiple apoptosis
pathways. The new findings also suggest that cell death
in flies is very similar to that in mammals after all. 
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The molecular mechanisms of apoptosis are highly con-
served throughout evolution. The homologs of genes
essential for apoptosis in Caenorhabditis elegans have been
shown to be important for apoptosis in mammalian
systems: the C. elegans ced-3 gene encodes a protein homol-
ogous to the mammalian caspase family of apoptotic pro-
teases [1]; ced-4 to mammalian apaf-1, which encodes an
adaptor protein that activates caspases [2]; and ced-9 to the
anti-apoptotic members of the bcl-2 family of mammalian
cell-death regulators [3]. In the case of Drosophila,
however, there has been speculation that the process of
apoptosis had somehow been modified. Although the exe-
cutioners of apoptosis, the caspases, were found to be con-
served in flies, neither apaf-1 nor bcl-2 homologs had been
reported. Three recent papers now report the identifi-
cation of a fly ced-4/apaf-1 homolog [4–6]. These groups
have named the gene dark, hac-1, and dapaf-1, respec-
tively: in the on-line Drosophila database the gene is called
ark, for apaf-1-related killer. Homologs of bcl-2 have also
been identified in flies (P. Kurada and K.W., unpublished
data, GenBank accession number AF216752; [5]). These
findings demonstrate that the mechanisms of apoptosis in
flies are very likely to be the same as those that occur in
worms and mammals.
Both C. elegans Ced-4 and mammalian Apaf-1 have already
been shown to act as facilitators of caspase activation
(reviewed in [7]). In worms, Ced-4 forms a complex with
Ced-3, enhancing Ced-3 activation. The anti-apoptotic
protein Ced-9 binds to Ced-4 and inhibits the activation of
Ced-3. Mammalian Apaf-1 seems to act in a similar
manner, binding to caspase 9 and promoting its auto-
activation. Anti-apoptotic members of the Bcl-2 family
inhibit this activity, although they may not bind directly to
Apaf-1. The recent Drosophila work shows that Ark also
binds to caspases, specifically to the recently identified
Dredd and Dronc proteases [4,6]. Overexpression of a
truncated form of Ark was able to induce apoptosis, and
this apoptosis was inhibited by co-expression of a catalyti-
cally inactive form of Dredd [4]. This finding suggests
that Ark binds to and activates Dredd, and that this activa-
tion is important for Ark’s pro-apoptotic activity. The cat-
alytically inactive Dredd may bind to Ark but would be
unable to undergo auto-activation. Understanding how the
Drosophila Bcl-2 homologs affect Ark function awaits their
full characterization.
One interesting difference between Apaf-1 and Ced-4 is
the presence of a WD-repeat domain in the mammalian
protein. This domain acts as an inhibitor of Apaf-1 func-
tion. Apaf-1 is also regulated by cytochrome c, which is
released from mitochondria into the cytosol as cells
undergo apoptosis. Cytochrome c binds to the WD-repeat
domains of Apaf-1 thereby relieving the negative regula-
tion [8]. Deletion of the WD-repeat domain results in the
generation of a constitutively active form of Apaf-1. In a
similar manner, truncation of Ark by removal of its WD
repeats also resulted in a potent apoptosis-inducing
protein. Thus, Apaf-1 and Ark have acquired a level of
regulation not seen with Ced-4. One of the groups
working on Ark has also observed the presence of two
forms of Ark, one that contains WD repeats and one that
does not [6]. This group has found that mouse Apaf-1 may
also be present in a form that lacks WD repeats. If this
latter observation is confirmed, it suggests that both Ark
and Apaf-1 function in cytochrome-c-dependent and
cytochrome-c-independent manners. The two forms of
Ark show differences in caspase binding specificity, and in
the types of caspase activity they induce when over-
expressed. Thus, the particular form of Ark that is
expressed may serve to modulate the apoptosis response.
One model that has been proposed for the role of the
Apaf-1–caspase-9 complex in apoptosis is that this
complex acts as part of an amplification cycle. This model
is based on the observation that, in the absence of Apaf-1,
some cells are resistant to a variety of pro-apoptotic signals
whereas other cells retain their sensitivity to these same
signals [9]. In the cells that do not require Apaf-1 in order
to undergo death, the apoptosis induction pathway is suffi-
cient to activate caspases to a level that kills the cell,
whereas in the resistant cells induction may lead only to
sublethal caspase activity. Amplification of the caspase
signal can be initiated by cytochrome c release from mito-
chondria, and subsequent derepression of Apaf-1. A recent
study of mice deficient in the pro-apoptotic BH3 protein
Bid suggests that Bid may be responsible for turning on
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this amplification cycle in response to activation of the Fas
pathway [10]. In Bid-deficient liver cells, some caspase
activation can be seen in response to Fas triggering. The
caspase activation is only seen near the plasma membrane,
however, and does not kill cells efficiently.
The data on Ark in flies supports the role of this protein in
such an amplification cycle. Localization of cytochrome c
was altered in response to both developmental inducers of
apoptosis, and to staurosporine and cycloheximide. In
Drosophila embryo extracts, cytochrome c was deduced to
be sufficient to induce caspase activity [6]. The work was
then taken a step further by showing that the WD-repeat
domains of Ark bound to cytochrome c [4,6] and, impor-
tantly, that caspase activation by cytochrome c was inhib-
ited in the absence of Ark [6]. Thus, the induction of
apoptosis can lead to Ark-dependent caspase activation in
response to altered cytochrome c localization. Apoptosis
could still occur in embryos lacking detectable Ark,
however, albeit at a greatly reduced level [4–6]. Thus,
some developmental apoptosis in flies may occur in the
absence of Ark-mediated amplification, while in other
cases the inductive signal is insufficient to induce apopto-
sis in the absence of Ark.
Apoptosis in Drosophila is regulated by three genes, head
involution defective (hid), reaper (rpr) and grim (reviewed
in [11]). In the absence of all three genes, apoptosis in the
developing embryo is completely blocked. These genes
are thought to induce apoptosis by binding to and inacti-
vating the inhibitor of apoptosis proteins or IAPs
(reviewed in [12]). IAPs prevent apoptosis by binding to
caspases and inhibiting their activity. To understand the
role that Ark plays in death induced by hid, rpr and grim,
genetic interactions were studied in transgenic flies in
which these genes were overexpressed in the eye, result-
ing in ectopic apoptosis. Allelic differences resulted in
variability in the results reported but, on balance, the data
suggest that death induced by all three of these cell-death
regulators is reduced in the absence of Ark [4]. This
finding supports the idea that Ark is a component of an
amplification cycle that is required for apoptosis in some
cells in response to several different inducers. The Ark
amplification cycle may represent an integration point for
regulatory inputs. In fact, the expression of Ark is high in a
subset of cells doomed to die during development and is
also increased following exposure of cells to ionizing radia-
tion [5]. Thus, Ark expression may serve to sensitize cells
to other death signals (Figure 1).
One of the strengths of the Drosophila system is the ability
to study the role of cell-death genes in the context of
normal development. It is interesting to note that flies
that lack detectable Ark are viable. In fact, it is still not
known whether apoptosis is essential for viability in
Drosophila. Flies deficient for Ark did show a variety of
phenotypes, however, some of which resembled those
resulting from mutations in other cell-death genes. The
Ark mutants had a gnarled or blistered wing phenotype
resembling that seen in flies lacking Hid, while the pres-
ence of extra bristles on Ark mutants is similar to the
phenotype seen in Dredd mutants [4]. Inhibition of cas-
pases during development also results in a similar bristle
phenotype [6]. Importantly, the enlarged central nervous
system reported in Ark mutants is like that seen in mice
lacking Apaf-1 [9]. One surprising finding is the presence
of extra photoreceptors in the eyes of Ark mutants. As the
specification of the correct number of photoreceptors is
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Figure 1
A speculative model for the relationship of
identified cell-death genes in Drosophila. The
cell-death regulatory proteins Hid, Reaper and
Grim induce apoptosis, at least in part, by
binding to and inactivating the anti-apoptotic
Drosophila IAPs. The IAPs usually inhibit the
activity of effector caspases, such as Dcp-1
and drICE. The proapoptotic signals generated
by Reaper, Grim and Hid may be amplified by
the mitochondrial pathway. Activated by the
release of cytochrome c, dArk promotes the
activation of Dredd and Dronc caspases, which
may in turn feedback and activate Dcp-1 and
drICE. Although Bcl-2 proteins have been
found in flies, their role in promoting or
inhibiting mitochondrial events has not yet been
demonstrated. The multiple components of this
pathway allow for many regulatory inputs, at
both the transcriptional and post-translational
levels. Regulatory pathways are shown in
purple, the initiation pathway in blue, the
caspases in red, and the mitochondrial
amplification components in green.
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not thought to involve apoptosis, this finding suggests that
Ark has roles in other developmental pathways. This is
clearly an intriguing area for further study. In addition,
insights into the subcellular localization of Ark and its
potential interaction with the Bcl-2 homologs may provide
new ideas about the role of these proteins in developmen-
tally regulated apoptosis.
In sum, the discovery of a fly Apaf-1 homolog demon-
strates that cell death in flies does, after all, have many
features in common with apoptosis in other organisms. It
is likely, given the progress of the fly and human genome
projects, that this conformation of common mechanisms
will flow both ways. It is clear that there are sophisticated
developmental controls of apoptosis in the fly that have
not been found in mammalian systems — specifically the
rpr, grim and hid genes. Of course, it is possible that these
genes are fly ‘inventions’, but it seems more likely that
the mammalian homologs are yet to be identified. In
either case, investigation of the developmental regulation
of apoptosis in the fly will certainly provide us with a
better understanding of the role and regulation of this
process in mammalian development and disease.
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If you found this dispatch interesting, you might also want
to read the April 1999 issue of
Current Opinion in
Cell Biology
which included the following reviews, edited
by Joan S Brugge and Frank McCormick,
on Cell regulation:
Regulation of tyrosine kinase cascades by G-protein-
coupled receptors
Louis M Luttrell, Yehia Daaka and Robert J Lefkowitz
Epidermal growth factor receptors: critical mediators
of multiple receptor pathways
Peter O Hackel, Esther Zwick, Norbert Prenzel 
and Axel Ullrich
Multiple positive and negative regulators of signaling
by the EGF-receptor
Nadeem Moghal and Paul W Sternberg
Interactions between mitogenic stimuli, or, a thousand
and one connections
Martin A Schwartz and Veronique Baron
Costimulatory regulation of T cell function
Cynthia A Chambers and James P Allison
Organization and regulation of mitogen-activated
protein kinase signaling pathways
Timothy P Garrington and Gary L Johnson
Signalling through phosphoinositide 3-kinases: the
lipids take centre stage
Sally J Leevers, Bart Vanhaesebroeck 
and Michael D Waterfield
Multiple signals converging on NF-κB
Frank Mercurio and Anthony M Manning
Regulation of LEF-1/TCF transcription factors by Wnt
and other signals
Quinn Eastman and Rudolf Grossched
In or out? Regulating nuclear transport
Jennifer K Hood and Pamela A Silver
Organization and regulation of proteins at synapses
Jee Hae Kim and Richard L Huganir
Apoptosis control by death and decoy receptors
Avi Ashkenazi and Vishva M Dixit
Deciphering the pathways of life and death
Honglin Li and Junying Yuan
Regulating the onset of mitosis
Ryoma Ohi, Kathleen L Gould
Bidirectional signaling between the cytoskeleton
and integrins
Simone M Schoenwaelder and Keith Burridge
The full text of Current Opinion in Cell Biology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/jcel
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